Erectile Dysfunction News and Research

Latest Erectile Dysfunction News and Research

PSA test benefits are questionable, yet physicians struggle to stop them

Recent recommendations from the U.S. Preventive Services Task Force (USPSTF) advising elimination of routine prostate-specific antigen (PSA) screening for prostate cancer in healthy men are likely to encounter serious pushback from primary care physicians, according to results of a survey by Johns Hopkins investigators.

24 May 2012

Experimental bariatric surgery can lower blood sugar levels in rats with type 1 diabetes

For the first time, scientists at the Toronto General Hospital Research Institute have shown that an experimental bariatric surgery can lower blood sugar levels in rats with type 1 diabetes.

21 May 2012

Older, high-risk prostate cancer patients get better results in larger hospitals

Older, sicker, high-risk patients who undergo one of the most common treatments for prostate cancer get better results in larger, busier hospitals, according to new research by Henry Ford Hospital.

16 May 2012

S1 Biopharma announces foray into male sexual health with S1P-205

S1 Biopharma, an early-stage biopharmaceutical company developing therapeutic solutions for Hypoactive Sexual Desire Disorder (HSDD) and related sexual dysfunctions, today announced its foray into male sexual health with S1P-205, the first and only drug in development for male HSDD.

14 May 2012

Sildenafil may improve cardiac function in children, young adults with single ventricle defects

Sildenafil, also known as the erectile dysfunction drug Viagra, may give a boost to underdeveloped hearts in children and young adults with congenital heart defects. Researchers from The Children's Hospital of Philadelphia report that sildenafil significantly improved echocardiographic measures of heart function in children and young adult survivors of single ventricle heart disease palliation.

9 May 2012

VIVUS receives FDA approval for Stendra to treat erectile dysfunction

The U.S. Food and Drug Administration today approved Stendra (avanafil), a new drug to treat erectile dysfunction.

30 Apr 2012

FDA approves VIVUS’ STENDRA for treatment of erectile dysfunction

VIVUS, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved STENDRA (avanafil) tablets for the treatment of erectile dysfunction (ED), marking the first new prescription agent approved in nearly a decade for the condition that afflicts as many as 30 million men in the U.S.

30 Apr 2012

IMRT facilitates radiation dose escalation without compromising long-term morbidity for prostate cancer

In an analysis of three different types of radiation therapy used to treat localized prostate cancer, compared with conformal radiation therapy, intensity-modulated radiation therapy (IMRT) was associated with fewer diagnoses of gastrointestinal adverse effects, hip fractures, and receipt of additional cancer treatments but more erectile dysfunction, while proton therapy was associated with more gastrointestinal adverse effects than IMRT.

18 Apr 2012

Oxytocin may offer hope for male sexual dysfunction

The hormone oxytocin that is also called the “love hormone” since it plays a role in the bond between a mother and baby may also improve sexual function - at least in men with Asperger’s syndrome - according to a published case report.

10 Apr 2012

New dietary supplement may arrest, lower rising PSA in men with recurrent prostate cancer

Preliminary findings from an FDA-approved clinical trial indicate that the experimental dietary supplement Prostate Health Cocktail (PHC) may arrest and in some cases lower rising PSA (Prostate Specific Antigen) in men with recurrent prostate cancer.

9 Apr 2012

Ampio submits pre-IND package on Zertane to FDA

Ampio Pharmaceuticals, Inc., a company that discovers and develops new uses for previously approved drugs and new molecular entities, announced today that it submitted to the FDA a pre IND package on Zertane, its on-demand premature ejaculation drug, for a meeting and discussion on the approval path under the 505(b) 2 regulation/registration requirement in the US.

9 Apr 2012

Majority of female kidney failure patients on dialysis may experience sexual problems

The vast majority of female kidney failure patients on dialysis may experience sexual problems, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society Nephrology (CJASN). Additional studies are needed to understand how sexual dysfunction affects dialysis patients' quality of life and psychological wellbeing.

6 Apr 2012

Only few OB-GYNs routinely inquire about patients' sexual issues

How often does your doctor ask about your sexual life? Unfortunately, the answer may be: not often enough. Leaving the subject off the check-up checklist could mean missing an important link to overall wellness.

23 Mar 2012

Virginia uproar frames abortion, contraception legislation in many states

States are grappling with reproduction-related issues after Virginia's pre-abortion ultrasound bill passed: In California, lawmakers are set to consider a bill to give more women access to early-term abortions while lawmakers in Ohio and Minnesota consider legislation on contraception.

11 Mar 2012

Contraception, abortion issues crop up in state legislatures, political races

The debate over the birth control mandate is seeping into West Virginia's governor race as reproductive-rights supporters assess their place amid losses in state legislatures.

9 Mar 2012

Neutra names new erectile dysfunction supplement as Pure Plus Powermax

Neutra Corp. announced today that its new all-natural erectile dysfunction supplement will be named Turbocharged Pure Plus Powermax.

6 Mar 2012

Abortion, contraception politics still on front burner as primaries loom

The political furor around abortion and contraception shows no sign of abating, according to news outlets.

27 Feb 2012

New erectile dysfunction supplement with Bio-Energy infusion

As Neutra Corp. works to finalize the formula for its new Pure Plus erectile dysfunction supplement, the company has already confirmed the new product's most important ingredient: The Bio-Energy infusion that will turbocharge the supplement's effectiveness.

24 Feb 2012

FDA EMDAC recommends approval of VIVUS' Qnexa for obesity

VIVUS, Inc. today announced that the U.S. Food and Drug Administration Endocrinologic and Metabolic Drugs Advisory Committee recommended Qnexa be granted marketing approval by the FDA for the treatment of obesity in adults.

23 Feb 2012

U.S. FDA accepts Pfizer's tafamidis NDA for treatment of TTR-FAP

Pfizer Inc. today announced that the U.S. Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for tafamidis meglumine, the company's investigational, novel, oral therapy for the treatment of Transthyretin Familial Amyloid Polyneuropathy.

16 Feb 2012

Erectile Dysfunction News and Research

Latest Erectile Dysfunction News and Research

PSA test benefits are questionable, yet physicians struggle to stop them

Experimental bariatric surgery can lower blood sugar levels in rats with type 1 diabetes

Older, high-risk prostate cancer patients get better results in larger hospitals

S1 Biopharma announces foray into male sexual health with S1P-205

Sildenafil may improve cardiac function in children, young adults with single ventricle defects

VIVUS receives FDA approval for Stendra to treat erectile dysfunction

FDA approves VIVUS’ STENDRA for treatment of erectile dysfunction

IMRT facilitates radiation dose escalation without compromising long-term morbidity for prostate cancer

Oxytocin may offer hope for male sexual dysfunction

New dietary supplement may arrest, lower rising PSA in men with recurrent prostate cancer

Ampio submits pre-IND package on Zertane to FDA

Majority of female kidney failure patients on dialysis may experience sexual problems

Only few OB-GYNs routinely inquire about patients' sexual issues

Virginia uproar frames abortion, contraception legislation in many states

Contraception, abortion issues crop up in state legislatures, political races

Neutra names new erectile dysfunction supplement as Pure Plus Powermax

Abortion, contraception politics still on front burner as primaries loom

New erectile dysfunction supplement with Bio-Energy infusion

FDA EMDAC recommends approval of VIVUS' Qnexa for obesity

U.S. FDA accepts Pfizer's tafamidis NDA for treatment of TTR-FAP

The evolution of OCT for retinal imaging and disease intervention

Supercharging Next-Gen Antibody Discovery with AI and High-Throughput Experimentation

Prof. Dr. Kristina Kusche-Vihrog

Erectile Dysfunction News and Research

Latest Erectile Dysfunction News and Research

The evolution of OCT for retinal imaging and disease intervention

Supercharging Next-Gen Antibody Discovery with AI and High-Throughput Experimentation

Prof. Dr. Kristina Kusche-Vihrog

Newsletters you may be interested in